BRPI0907802A2 - biomarcador para lesão renal aguda e estimativa de seu prognóstico, e sua aplicação - Google Patents

biomarcador para lesão renal aguda e estimativa de seu prognóstico, e sua aplicação

Info

Publication number
BRPI0907802A2
BRPI0907802A2 BRPI0907802A BRPI0907802A BRPI0907802A2 BR PI0907802 A2 BRPI0907802 A2 BR PI0907802A2 BR PI0907802 A BRPI0907802 A BR PI0907802A BR PI0907802 A BRPI0907802 A BR PI0907802A BR PI0907802 A2 BRPI0907802 A2 BR PI0907802A2
Authority
BR
Brazil
Prior art keywords
biomarker
prognosis
estimation
application
kidney injury
Prior art date
Application number
BRPI0907802A
Other languages
English (en)
Inventor
Hiroki Hayashi
Kenji Kadomatsu
Seiichi Matsuo
Shinya Ikematsu
Yukio Yuzawa
Original Assignee
Univ Nagoya Nat Univ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nagoya Nat Univ Corp filed Critical Univ Nagoya Nat Univ Corp
Publication of BRPI0907802A2 publication Critical patent/BRPI0907802A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/515—Angiogenesic factors; Angiogenin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
BRPI0907802A 2008-02-29 2009-02-26 biomarcador para lesão renal aguda e estimativa de seu prognóstico, e sua aplicação BRPI0907802A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2008048954 2008-02-29
JP2008302443 2008-11-27
JP2008302444 2008-11-27
PCT/JP2009/000863 WO2009107384A1 (ja) 2008-02-29 2009-02-26 急性腎障害及び予後推定用バイオマーカー並びにその用途

Publications (1)

Publication Number Publication Date
BRPI0907802A2 true BRPI0907802A2 (pt) 2016-08-23

Family

ID=41015791

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907802A BRPI0907802A2 (pt) 2008-02-29 2009-02-26 biomarcador para lesão renal aguda e estimativa de seu prognóstico, e sua aplicação

Country Status (8)

Country Link
US (1) US20110111427A1 (pt)
EP (1) EP2261660B1 (pt)
JP (1) JP4423375B2 (pt)
KR (1) KR20100122495A (pt)
CN (1) CN101960308B (pt)
BR (1) BRPI0907802A2 (pt)
CA (1) CA2716854A1 (pt)
WO (1) WO2009107384A1 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ610356A (en) 2008-08-28 2015-03-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2010025434A1 (en) 2008-08-29 2010-03-04 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN104399089B (zh) 2008-10-21 2017-04-19 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
NZ592488A (en) 2008-11-10 2012-10-26 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN104034901A (zh) * 2008-11-22 2014-09-10 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
US9229010B2 (en) 2009-02-06 2016-01-05 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP2012525571A (ja) * 2009-04-30 2012-10-22 エフ．ホフマン−ラ ロシュ アーゲー 適切な治療を必要とする個体において心不全関連腎臓損傷を診断するための手段及び方法
NZ598034A (en) 2009-08-07 2014-06-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011057147A1 (en) * 2009-11-07 2011-05-12 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3246708A3 (en) * 2009-12-18 2018-01-03 Roche Diagnostics GmbH Troponins for predicting kidney failure in heart surgery patients
MX342967B (es) 2009-12-20 2016-10-19 Astute Medical Inc Metodos y composiciones para la diagnosis y prognosis de lesion renal y falla renal.
JP2013519095A (ja) 2010-02-05 2013-05-23 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
KR20140051754A (ko) 2010-02-26 2014-05-02 아스튜트 메디컬 인코포레이티드 신장 손상 및 신부전의 진단 및 예후를 위한 방법 및 조성물
JP5555374B2 (ja) * 2010-06-15 2014-07-23 エフ．ホフマン−ラ ロシュ アーゲー 外科処置後の急性腎傷害の予測および認識
WO2011162821A1 (en) 2010-06-23 2011-12-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ703055A (en) 2010-06-23 2016-07-29 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US10557856B2 (en) * 2010-09-24 2020-02-11 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Biomarkers of renal injury
CN102122579A (zh) * 2010-12-08 2011-07-13 天津理工大学 一种碳纳米管阵列光阴极材料及其制备方法和应用
CN102243241A (zh) * 2011-04-07 2011-11-16 武汉生之源生物科技有限公司 一种匀相溶胶颗粒型中性粒细胞明胶酶相关脂质运载蛋白测定试剂盒及其制备方法
EP2729803A4 (en) * 2011-07-09 2015-08-05 Astute Medical Inc METHODS AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING RENAL INJURY AND RENAL FAILURE
US9459261B2 (en) 2011-08-26 2016-10-04 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2568291A1 (en) * 2011-09-07 2013-03-13 Roche Diagnostics GmbH L-FABP based diagnosis of kidney injury after an acute event or after a surgical intervention
US10935548B2 (en) 2011-12-08 2021-03-02 Astute Medical, Inc. Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2
WO2013183596A1 (ja) * 2012-06-06 2013-12-12 国立大学法人名古屋大学 腎疾患のバイオマーカー及びその用途
GB201210587D0 (en) * 2012-06-14 2012-08-01 Belfast Health And Social Care Trust Predictive biomarker
GB201214440D0 (en) * 2012-08-13 2012-09-26 Randox Lab Ltd Kidney disease biomarker
AU2014207509B2 (en) 2013-01-17 2019-12-12 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3465201A4 (en) 2016-06-06 2020-08-26 Astute Medical, Inc. MANAGEMENT OF ACUTE KIDNEY DAMAGE USING INSULINOMIMETIC GROWTH FACTOR BINDING PROTEIN 7 AND TISSUE METALLOPROTEINASE 2 INHIBITOR
CN110431422A (zh) 2017-02-06 2019-11-08 机敏医药股份有限公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
WO2020071518A1 (ja) * 2018-10-04 2020-04-09 学校法人自治医科大学 急性腎障害特異的バイオマーカー、急性腎障害の診断方法、急性腎障害の検査用キット、動物治療方法、及び急性腎障害用医薬
CN112048551A (zh) * 2020-08-25 2020-12-08 朱永俊 一种慢性肾小球疾病肾小球硬化标志物及其检测试剂盒
WO2023063331A1 (ja) * 2021-10-14 2023-04-20 国立大学法人東海国立大学機構 抗３'，４'－ジデヒドロ－３'－デオキシシチジン抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10160735A (ja) 1996-01-19 1998-06-19 Meiji Milk Prod Co Ltd サンドイッチ測定法
JP2000266750A (ja) * 1999-03-16 2000-09-29 Meiji Milk Prod Co Ltd ミッドカインの免疫学的測定方法
WO2001020333A1 (fr) * 1999-09-10 2001-03-22 Meiji Milk Prod Co Ltd Marqueur de tumeur pour les cancers a un stade precoce
US20050214292A1 (en) * 2002-10-18 2005-09-29 Wyeth Compositions and methods for diagnosing and treating autoimmune disease
NZ592488A (en) * 2008-11-10 2012-10-26 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Also Published As

Publication number Publication date
JPWO2009107384A1 (ja) 2011-06-30
WO2009107384A1 (ja) 2009-09-03
US20110111427A1 (en) 2011-05-12
EP2261660A1 (en) 2010-12-15
EP2261660A4 (en) 2011-03-23
CA2716854A1 (en) 2009-09-03
KR20100122495A (ko) 2010-11-22
JP4423375B2 (ja) 2010-03-03
CN101960308A (zh) 2011-01-26
CN101960308B (zh) 2014-07-09
EP2261660B1 (en) 2013-08-07

Similar Documents

Publication Publication Date Title
BRPI0907802A2 (pt) biomarcador para lesão renal aguda e estimativa de seu prognóstico, e sua aplicação
BRPI1010885A2 (pt) motivos de modificação química para inibidores mirna e miméticos.
BRPI0919296A2 (pt) biomarcadores urinários para prevenção de díalise de longa duração
BRPI0812073A2 (pt) Laminado para moldagem de encaixe e método de sua fabricação, e moldagem de encaixe e método de sua fabricação
BRPI0812448A2 (pt) Método para aperfeiçoamento de propriedades de proteína
BRPI0923159A2 (pt) gene de delta-endotoxina axmi-150 e métodos para sua utilização.
BRPI0924258A2 (pt) métodos para otimizar e para determinar desempenho de reservatório
BRPI0918550A2 (pt) projeto de sinal de referência para lte avancada
CL2008000173S1 (es) Dispositivo de refuerzo para bordes.
BRPI0819127A2 (pt) Método para cimentar.
BRPI0820153A2 (pt) Aperfeiçoamento de ação direta para rifles
BRPI0911758A2 (pt) anticorpos para receptor de produtos finais de glicação avançada (rage) e utilizações dos mesmos
BRPI0919975A2 (pt) imunoensaio para galectina-3
BRPI0812130A2 (pt) Interfaces para processamento de mídia digital
EP2668497A4 (en) URINBIOMARKER FOR PREDICTING RECOVERY AFTER ACUTE VIOLATION: PROTEOMICS
BRPI0920788A2 (pt) extensões de processadores para execução de recipientes embutidos seguros
BRPI0909115A2 (pt) métodos e entidades para tranferência inter-domínio
BRPI0923199A2 (pt) métodos e composições para detecção de anticorpos com fixação de complemento.
BRPI0913194A2 (pt) método para medir fluxo multifásico
BRPI1008692A2 (pt) moléculas de anticorpos tendo especificidade para ox40 humano.
BRPI0815725A2 (pt) Métodos para detecção de oligonucleotídeos
BRPI0916521A2 (pt) método e sistema para processamento submarino de efluentes de poço de multifases
BRPI0908201A2 (pt) detecção de multipercursos para sinal sps recebido
BRPI0918157A2 (pt) acessório em y para raspa-tubos
CR10705A (es) Anticuerpos para linfotoxina-alfa

Legal Events

Date Code Title Description
B11Z Dismissal: petition dismissal - article 216, par 2 of industrial property law

Free format text: PROMULGA-SE O ARQUIVAMENTO DA PETICAO DE ENTRADA NA FASE NACIONAL POR INTEMPESTIVIDADE DE APRESENTACAO DA PROCURACAO CONFORME APRESENTADO NO ART. 216 2O DA LPI (LEI 9279/1996) E DA RESOLUCAO INPI-PR NO 77/2013, ART. 31. DESTA DATA, CORRE O PRAZO DE 60 (SESSENTA) DIAS PARA EVENTUAL RECURSO DO INTERESSADO CONFORME APRESENTADO NO ART. 212 DA LPI (LEI 9279/1996) E DA RESOLUCAO INPI-PR NO 77/2013, ART. 31, PARAGRAFO UNICO.

B11M Decision cancelled [chapter 11.13 patent gazette]

Free format text: ANULACAO DA PUBLICACAO CODIGO 11.6.1 NA RPI NO 2374 DE05/07/2016, POR TER SIDO INDEVIDA.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2503 DE 26-12-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]